Rising Pharma Holding, Inc. recalls

All Rising Pharma Holding, Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (10).

10 recalls published between December 11, 2024 and July 29, 2026. Most common issues: manufacturing practices (cgmp) (7).

• Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT)… recall
  FDA July 29, 2026 · Rising Pharma Holding, Inc. · Class II
• Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles… recall
  FDA March 11, 2026 · Rising Pharma Holding, Inc. · Class II
• Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg… recall
  FDA October 22, 2025 · Rising Pharma Holding, Inc. · Class II
• Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle… recall
  FDA March 26, 2025 · Rising Pharma Holding, Inc. · Class II
• Duloxetine DR Capsules USP 60 mg, a) 30 count ( recall
  FDA January 15, 2025 · Rising Pharma Holding, Inc. · Class II
• Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only… recall
  FDA January 15, 2025 · Rising Pharma Holding, Inc. · Class II
• Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count ( recall
  FDA January 15, 2025 · Rising Pharma Holding, Inc. · Class II
• Duloxetine DR Capsules USP 60 mg, a) 30 count ( recall
  FDA December 11, 2024 · Rising Pharma Holding, Inc. · Class II
• Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count ( recall
  FDA December 11, 2024 · Rising Pharma Holding, Inc. · Class II
• Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only… recall
  FDA December 11, 2024 · Rising Pharma Holding, Inc. · Class II